Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection-Reference-Cited by-同舟云学术

Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection

Published:2011-06 Issue:6 Volume:54 Page:1114-1122
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Manns Michael P.,Bourlière Marc,Benhamou Yves,Pol Stanislas,Bonacini Maurizio,Trepo Christian,Wright David,Berg Thomas,Calleja José L.,White Peter W.,Stern Jerry O.,Steinmann Gerhard,Yong Chan-Loi,Kukolj George,Scherer Joe,Boecher Wulf O.

Publisher

Elsevier BV

Subject

Hepatology

Reference22 articles.

1. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

2. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

3. The way forward in HCV treatment – finding the right path;Manns;Nat Rev Drug Discov,2007

4. Sustained virologic response after peginterferon alfa-2b and ribavirin treatment predicts long-term clearance of HCV at 5-year follow-up;Manns;J Hepatol,2008

5. Diagnosis, management, and treatment of hepatitis C: an update;Ghany;Hepatology,2009

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C Virus;Current Medicinal Chemistry;2023-10-19

2. Effect of itraconazole on the pharmacokinetics of faldaprevir in healthy subjects;PHARMAZIE;2021

3. Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant;ACS Omega;2019-10-02

4. Identification of 19 Novel Hepatitis C Virus Subtypes—Further Expanding HCV Classification;Open Forum Infectious Diseases;2019-02-22

5. Interferon-Free Regimen: Equally Effective in Treatment Naive and Experienced HCV Patients;Annals of Hepatology;2019-01